|
Volumn 32, Issue 4, 2006, Pages 604-
|
When a single pivotal trial should not be enough-the case of drotrecogin-alfa (activated) [1]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DROTRECOGIN;
CLINICAL TRIAL;
COMMERCIAL PHENOMENA;
DRUG APPROVAL;
DRUG SCREENING;
HUMAN;
INTENSIVE CARE;
LETTER;
PRACTICE GUIDELINE;
SEPSIS;
CLINICAL TRIALS AS TOPIC;
DRUG APPROVAL;
DRUG TOXICITY;
HUMANS;
PROTEIN C;
RECOMBINANT PROTEINS;
|
EID: 33645106226
PISSN: 03424642
EISSN: None
Source Type: Journal
DOI: 10.1007/s00134-006-0086-9 Document Type: Letter |
Times cited : (15)
|
References (7)
|